CD8A and neoplasm: CLEC-1 (C-type lectin) binds to conserved protein structures exposed during programmed cell death, promoting tumor progression by facilitating immunosuppressive tumor microenvironment and hindering DC from cross-presenting dead cell-associated antigens to CD8+T cells (67).